tiprankstipranks
Contineum Therapeutics, Inc. Class A (CTNM)
NASDAQ:CTNM
US Market

Contineum Therapeutics, Inc. Class A (CTNM) Technical Analysis

154 Followers

Technical Sentiment

Overall Consensus
Buy
8Bullish
5Neutral
5Bearish
Technical Analysis Consensus
Buy
5Bullish
5Neutral
0Bearish
Moving Average Consensus
Sell
3Bullish
0Neutral
5Bearish
Contineum Therapeutics, Inc. Class A’s (CTNM) Moving Averages Convergence Divergence (MACD) indicator is 0.94, suggesting Contineum Therapeutics, Inc. Class A is a Buy.
Contineum Therapeutics, Inc. Class A’s (CTNM) 20-Day exponential moving average is 20.07, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $20.15, making it a Buy.
Contineum Therapeutics, Inc. Class A’s (CTNM) 50-Day exponential moving average is 18.41, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $20.15, making it a Buy.

Contineum Therapeutics, Inc. Class A (CTNM) Pivot Points

Jul 22, 2024, 10:17 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
19.63
20.14
20.58
21.09
21.53
22.04
22.48
Fibonacci
20.14
20.50
20.72
21.09
21.45
21.67
22.04
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Contineum Therapeutics, Inc. Class A (CTNM) Moving Averages

Jul 22, 2024, 10:17 AM
Period
Simple
Exponential
MA5
21.00Sell
20.77Sell
MA10
20.93Sell
20.70Sell
MA20
20.30Sell
20.07Buy
MA50
17.76Buy
18.41Buy
Contineum Therapeutics, Inc. Class A’s (CTNM) 10-Day exponential moving average is 20.70, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $20.15, making it a Sell.
Contineum Therapeutics, Inc. Class A’s (CTNM) stock price is $20.15 and Contineum Therapeutics, Inc. Class A’s (CTNM) 50-day simple moving average is 17.76, creating a Buy signal.

Contineum Therapeutics, Inc. Class A (CTNM) Technical Indicators

Jul 22, 2024, 10:17 AM
Name
Value
Implied Action
RSI (14)
53.25
Neutral
STOCH (9,6)
64.87
Neutral
STOCHRSI (14)
73.96
Neutral
MACD (12,26)
0.94
Buy
ADX (14)
19.69
Buy
Williams %R
-41.95
Buy
CCI (14)
33.86
Neutral
ATR (14)
1.47
-
Ultimate Oscillator
49.25
Neutral
ROC
14.42
Buy
Contineum Therapeutics, Inc. Class A’s (CTNM) Relative Strength Index (RSI) is 53.25, creating a Neutral signal.
Contineum Therapeutics, Inc. Class A’s (CTNM) Trend Strength Indicator (ADX) is 19.69, creating a Buy signal.
Contineum Therapeutics, Inc. Class A’s (CTNM) Commodity Channel Index (CCI) is 33.86, creating a Neutral signal.
Contineum Therapeutics, Inc. Class A’s (CTNM) Price Rate of Change (ROC) is 14.42, creating a Buy signal.

FAQ

Is CTNM a Buy, Hold, or Sell?
Based on CTNM’s technical indicators, CTNM is a Buy.
    What is CTNM’s RSI (14)?
    CTNM’s RSI (14) is 53.25, which suggests CTNM is a Neutral.
      What is CTNM’s MACD?
      CTNM’s MACD is 0.94, which suggests CTNM is a Buy.
        What is CTNM’s 5-day moving average?
        CTNM’s 5-day moving average is 21.00, which suggests CTNM is a Sell.
          What is CTNM’s 20-day moving average?
          CTNM 20-day moving average is 20.30, which suggests CTNM is a Sell.
            What is CTNM’s 50-day moving average?
            CTNM’s 50-day moving average is 17.76, which suggests CTNM is a Buy.
              What is CTNM’s 200-day moving average?
              Currently, no data Available
              What is CTNM’s Williams % R (14)?
              CTNM’s Williams % R (14) is -41.95, which suggests CTNM is a Buy.
                What is CTNM’s CCI (14)?
                CTNM’s CCI (14) is 33.86, which suggests CTNM is a Neutral.
                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis